What’s the change in treatment? The big change is when men with prostate cancer are given a drug called abiraterone. Currently, only patients whose cancer has spread (metastasized) to other parts of the body receive this drug. Men whose cancers haven’t spread beyond the original site yet – that is, with “locally advanced prostate cancer” – are offered surgery, radiotherapy, or hormonal therapy. This study, however, shows that giving abiraterone sooner (to men with locally advanced disease) can reduce the long-term risk of death from the disease by about a half.
Try our 7-day free trial and access the full article with citations and resources.